Catalyst Wire Dossier Catalyst Wire Dossier

Nilotinib

nilotinib · Novartis
Drug timelines are a Plus or Pro feature.

97 regulatory and trial events tracked for Nilotinib, covering 2010-03-19 to 2026-07-23. Get the full timeline:

Most recent: Clinical Trial Results: Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease [Phase 2]

See pricing